Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Similar documents
Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Application Note. Author. Abstract. Introduction. Food Safety

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Application Note. Authors. Abstract. Food

Author. Introduction. Small Molecule Pharmaceuticals & Generics

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Application Note. Abstract. Authors. Pharmaceutical

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Rapid and Robust Detection of THC and Its Metabolites in Blood

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

LC/MS/MS of Buprenorphine and Norbuprenorphine in Whole Blood Using Agilent Bond Elut Plexa PCX and an Agilent Poroshell 120 Column

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Authors. Abstract. Introduction. Environmental

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Quantitative Analysis of Amphetamine-Type Drugs by Extractive Benzoylation and LC/MS/MS. Application. Introduction. Authors. Abstract.

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

Vitamin D3 and related compounds by ESI and APCI

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Determination of Amantadine Residues in Chicken by LCMS-8040

Supporting Information

Determination of Multi-Residue Tetracyclines and their Metabolites in Milk by High Performance Liquid Chromatography - Tandem Mass Spectrometry

Determination of Benzodiazepines in Urine by CE-MS/MS

Multiclass Mycotoxin Analysis in Cheese Using Agilent Captiva EMR Lipid Cleanup and LC/MS/MS

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Fat-Soluble Vitamins Analysis on an Agilent ZORBAX Eclipse PAH Polymeric C18 Bonded Column

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions

High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column

LC/MS/MS Analysis of Metabolites of Synthetic Cannabinoids JWH-018 and JWH-073 in Urine

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Highly sensitive simultaneous quantitative analysis of estrone and equilin from plasma using LC/MS/MS

Author. Introduction. Abstract

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

AppNote 4/2015. Automated Desorption, SPE Extraction, and LC/MS/MS Analysis of Dried Blood Spots KEYWORDS ABSTRACT

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

Improved Isolation and Analysis of Mycotoxins from Cereals, Beer and Wine

Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Converting a CHP Method for Insulin to Agilent Poroshell 120 Columns

Protein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates

Dienes Derivatization MaxSpec Kit

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

Lipidomic Analysis by UPLC-QTOF MS

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Integration of steroids analysis in serum using LC-MS/MS with full-automated sample preparation

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

Automated Hydrolysis, Extraction and Determination of Opioids in Urine using a Novel Robotic Autosampler and LC-MS/MS Platform

Edgar Naegele. Abstract

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

Fully Using Agilent High Efficiency Columns with LC/MS

Agilent 6460 LC-QQQ Highly Sensitive and Robust Analysis for Lipophilic Marine Toxins in Shellfish

Determination of Eight Estrogens in Milk by UHPLC and the Agilent 6495 Triple Quadrupole Mass Spectrometer

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Highly Repeatable Ultra Low Detection of Estradiol Using Triple Quadrupole GC/MS in NCI Mode

Fully Automated Online Sample Preparation AND Quantification of Amiodarone from Whole Blood using CLAM-LC-MS/MS

Agilent 6470 Triple Quadrupole LC/MS System and EMR-Lipid. The Combination for Confident Pesticide Quantitation. Christoph Mueller

Transcription:

Analyze Barbiturates in Urine with Agilent 6 LC/MS/MS and Poroshell EC-C8 Application ote Forensic Toxicology Authors Elijah Steinbauer and Pat Friel Toxicology Laboratory at the Veterans Administration 7 SW US Veterans ospital Rd, Portland, R 979 Rongjie Fu and Andy Zhai Agilent Technologies (Shanghai) Co. Ltd Abstract A fast, cost-effective, and highly sensitive analytical method was developed for the determination of five barbiturates with four internal standards (ISTs) in urine using an Agilent 6 Triple Quadrupole LC/MS System and an Agilent Poroshell EC-C8 column. The sample of urine was extracted using an Agilent SPEC-C8AR cartridge. Results indicate that the analytical method effectively extracts the selected barbiturates from urine, resolving the target compounds and the ISTs in 8.5 minutes. Though amobarbital and pentobarbital differ only in the position of a methyl group, and are, hence, difficult to separate, their resolution is sufficient for analysis.

Materials and Methods Table lists the target compounds of barbiturates. All compounds were purchased from Cerilliant Corporation, Round Rock, TX, United States. Sample preparation. Begin by centrifuging the urine sample at,8 rpm for 5 minutes.. Pipette ml of centrifuged sample into a mm borosilicate glass tube.. Add exactly 5 μl of the working deuterated internal standard (butalbital-5, pentobarbital-5, secobarbital- 5, and phenobarbital-5).. Pipette 5 μl. M phosphate buffer into the sample. The phosphate buffer is prepared by adding.6 g K P into 8 ml water, adjusting to p 6. with K, then making the volume L. 5. Use a vacuum chamber with the Agilent SPEC-C8AR cartridge for extraction. Condition the cartridge with. ml of Me and load the sample solution. 6. Wash the column with ml water and dry for minute. 7. Elute the cartridge with ml 9: hexane:ethyl acetate mixture. 8. Collect the eluent and dry the sample under nitrogen gas at 5 C. 9. Reconstitute with ml 9: water:acetonitrile mixture. Table. Compounds used in this study. o. Compound CAS no. Structure o. Compound CAS no. Structure Phenobarbital-d5 779-6-5 6 Pentobarbital 76-7- 7 Amobarbital 57-- Phenobarbital 5-6-6 Butalbital-d5 5-96-5 8 Secobarbital-d5-7-7 9 Secobarbital 76-7- Butalbital 77-6-9 5 Pentobarbital-d5 59-66-8

The method was performed on the Agilent 6 Infinity LC with a 6 Triple Quadrupole LC/MS. PLC conditions Column Agilent Poroshell EC-C8,. mm,.7 μm (p/n 695775-9) Sample prep Agilent SPEC-C8CR, ml, 5 mg (p/n A59) Eluent A, 5 mm ammonium acetate; B, LC/MS grade acetonitrile Injection volume μl Flow rate. ml/min Gradient Time (min) % B 5 9 9.5 Temperature 6 C MS conditions ESI rying gas 5 C, L/min ebulize psi egative ionization mode Capillary, V, EMV This Agilent 6 Infinity LC did not have a low delay volume configuration. If running with low delay volume, use about minute initial hold. Results and iscussion Separation The superficially porous particles of Poroshell have nearly identical efficiency as sub- μm totally porous materials and can, therefore, be used to provide similarly fast and high resolution analyses at a lower pressure. A separation of the nine barbiturates in 8.5 minutes was achieved on the column Table. ptimized MRM conditions. o. Compound Ion pair qualitative and quantitative analyses RT (min) Phenobarbital-d5 6. &.; 6. & 9..85 Phenobarbital. &.;. & 88..87 Butalbital-d5 8. &.; 8. & 85. 6.5 Butalbital. &.;. & 8. 6.5 5 Pentobarbital-d5. &.;. & 87. 7.8 6 Pentobarbital 5. &.; 5. & 8. 7.75 7 Amobarbital 5. &.; 5. & 8. 7.85 8 Secobarbital-d5. &.;. & 99. 8.8 9 Secobarbital 7. & 6; 7. & 9. 8.55 with a gradient method (Figure ). Reasonable resolution was achieved between the standard components, except for pentobarbital and amobarbital. They are the isomers with the same product ions, which could not be identified by MS. owever, they still have some separation on Poroshell EC-C8 and the resolution for amobarbital and pentobarbital is sufficient for analysis...9.8.7 Cpd : Phenobarbital-d5: -ESI MRM Frag=95.V (6. & 9.) C SPE.d Butalbital Amobarbital Pentobarbital Secobarbital Secobarbital-d5 Counts (%).6.. Phenobarbital-d5 Phenobarbital Butalbital-d5 Pentobarbital-d5.. -....6.8 5. 5. 5. 5.6 5.8 6. 6. 6. 6.6 6.8 7. 7. 7. 7.6 7.8 8. 8. 8. 8.6 Acquisition time (min) Figure. MRM chromatograms of barbiturates and internal standards using an Agilent Poroshell EC-C8 column.

Linearity and recovery The stock standards solution, containing phenobarbital, butalbital, pentobarbital, amobarbital, and secobarbital, was diluted to a series of linear solutions of,,,5, and 5 ng/ml. In each solution, the ISTs of phenobarbital-d5, butalbital-d5, pentobarbital-d5, and secobarbital-d5, were made up to a concentration of, ng/ml. The calibration curves resulting from these standard injections on the Poroshell EC-C8 column using the 6 Triple Quadrupole LC/MS System are shown in Figure. The method showed excellent linearity, being very close to. (from.9995 to.99998)..5.5.5.5.5.5.5.5 Phenobarbital - Levels, Levels Used, Points, Points Used, QCs y =.9*x.65 R =.9999876 8,,6,,,8, Butalbital - Levels, Levels Used, Points, Points Used, QCs y =.5*x.598 R =.99955 8,,6,,,8, Secobarbital - Levels, Levels Used, Points, Points Used, QCs.5 y =.*x.69 R =.999776.5.5 8,,6,,,8, 8 7 6 5 Pentobarbital - Levels, Levels Used, Points, Points Used, QCs y =.5*x.576 R =.99996 Figure. Calibration curves of standards on an Agilent Poroshell EC-C8 column. 8,,6,,,8, Amobarbital - Levels, Levels Used, Points, Points Used, QCs. y =.856*x.95.9 R =.999956.8.7.6.... 8,,6,,,8,

The standards, at a concentration of 5 ng/ml, were spiked into the urine sample blank and processed with the SPE procedure. The recoveries were calculated and are shown in Table. Sample analysis Two samples of urine were analyzed followed by the method described above. Concentrations of five barbiturates could be calculated according to the calibration curves in Figure, and the data are listed in Table. Conclusions A method was developed for the extraction and separation of barbiturates using an Agilent SPEC-C8AR for sample extraction and an Agilent Poroshell EC-C8 column for separation. The sample preparation method effectively extracted the selected barbiturates from urine, with sufficient recoveries and precision. The column provided good selectivity and good resolution for these compounds. The analytical method developed on the Agilent 6 Triple Quadrupole LC/MS System was suitable for quantitative analysis of these compounds in urine, especially at low concentration levels. Table. Recoveries of barbiturates from a urine sample with SPE. Compounds Phenobarbital Butalbital Amobarbital Pentobarbital Secobarbital Recovery % (5 ng/ml) 6.6 87. 5.8 9.7 97.8 Table. Concentrations of the target barbiturates in urine samples. Phenobarbital Butalbital Pentobarbital Amobarbital Secobarbital Sample (ng/ml).5 8. 6.8. 6. Sample (ng/ml),.6,5. 5.8 97.,.9 5

For More Information These data represent typical results. For more information on our products and services, visit our Web site at www.agilent.com/chem. www.agilent.com/chem For Forensic Use only. Information is subject to change without notice. Agilent Technologies, Inc., Printed in the USA June, 599-596E